Compared with anastrozole alone, the combination of fulvestrant and anastrozole significantly improved time without disease progression and extended the median overall survival of women with endocrine ...

Aromatase inhibitors are an effective and well tolerated neoadjuvant treatment with improved efficacy for postmenopausal women with breast cancer compared with tamoxifen. Moreover, neoadjuvant ...

High-Dose Versus Standard Chemotherapy in Metastatic Breast Cancer: Comparison of Cancer and Leukemia Group B Trials With Data From the Autologous Blood and Marrow Transplant Registry PURPOSE: To ...

Please provide your email address to receive an email when new articles are posted on . SAN ANTONIO — Postmenopausal women with ductal carcinoma in situ experienced comparable rates of recurrence but ...

Effects of Exemestane Administered for 2 Years Versus Placebo on Bone Mineral Density, Bone Biomarkers, and Plasma Lipids in Patients With Surgically Resected Early Breast Cancer Tamoxifen, which is ...

Daily anastrozole therapy given to postmenopausal women who are at high risk of breast cancer, with the intention of preventing breast cancer occurrence, does not cause impairment of cognitive ...

has found that hormone levels, measured through blood tests, are an important indicator of whether women will benefit from recently licensed medication for the prevention of breast cancer. Research ...

A study by researchers from Queen Mary University of London shows that bone loss known to be associated with the use of the breast cancer prevention drug Anastrozole partially reverses, particularly ...

Anastrozole, a daily pill used to treat hormone-driven breast cancers, has been cleared for wider use in the UK. Previously, it was not licensed for prevention. Trials have shown that anastrozole can ...

The Queen Mary University of London professor leading an international breast cancer study says anastrozole - rather than tamoxifen - should be the preventive drug-of-choice for post-menopausal women ...

September 8, 2008 — The foveas of women using anastrozole to prevent breast cancer recurrence appear to be subjected to more tractional force than the foveas of women not using any hormonal medication ...

Please provide your email address to receive an email when new articles are posted on . SAN ANTONIO — The survival benefit postmenopausal patients with breast cancer derive from anastrozole vs.